Psychedelic Identity Disruption

Psychedelic identity disruption is the episode’s risk frame for profound psychological change after intense psychedelic experience. In Bryan Johnson: I Just Took the Most Powerful Dose of DMT in the World… Here’s What It Was Like, the All-In hosts ask Bryan Johnson whether 5-MeO-DMT can change a person’s values, duties, relationships, religion, family commitments, or founder responsibilities so much that continuity becomes ethically unclear.

The source treats this as more than a bad-trip problem. Johnson says his own experience made him more committed to his work, but the hosts cite cases where people left companies, families, or obligations after intense psychedelics. That makes the concept adjacent to Founder Risk Taking and Founder Risk Calibration: a founder’s private self-modification can become a governance and stakeholder risk if it changes priorities abruptly.

Key Claims

• Psychedelic transformation can be experienced as healing, but it may also alter values and obligations.
• The source separates acute psychiatric danger from slower life-disruption risk.
• Investor or founder restrictions on psychedelics are mentioned as a possible governance response, not as an endorsed solution.
• Family, partners, employees, and investors can become affected parties when self-experimentation changes a person’s commitments.

Connections

• Bryan Johnson and 5-MeO-DMT - source case.
• Default Mode Network and Psychedelic Longevity Hypothesis - mechanism and claimed upside.
• Self-Experimentation, Medical Risk Management, and Experimental Science Ethics - ethical and safety boundaries.
• Founder Risk Taking, Founder Risk Calibration, Founder Health Debt, and Achievement Pressure Mental Health - startup-risk and performance-pressure context.